Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab

PURPOSE: Daratumumab treatment results in a marked reduction of CD38 expression on multiple myeloma (MM) cells. The aim of this study was to investigate the clinical implications and the underlying mechanisms of daratumumab-mediated CD38 reduction. EXPERIMENTAL DESIGN: We evaluated the effect of dar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Krejcik, Jakub, Frerichs, Kris A., Nijhof, Inger S., van Kessel, Berris, van Velzen, Jeroen F., Bloem, Andries C., Broekmans, Marloes E.C., Zweegman, Sonja, van Meerloo, Johan, Musters, René J.P., Poddighe, Pino J., Groen, Richard W.J., Chiu, Christopher, Plesner, Torben, Lokhorst, Henk M., Sasser, A. Kate, Mutis, Tuna, van de Donk, Niels W.C.J.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732844/
https://ncbi.nlm.nih.gov/pubmed/29025767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2027
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items